Patents
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/1997
12/17/1997CN1167620A Donkey-hide gelatin calcium oral liquor and its producing process
12/17/1997CN1036701C Method for preparation of black-bone chicken extract
12/17/1997CN1036697C Method of preparing active nutriment from tortoise and/or soft-shelled turtle
12/16/1997US5698594 Treatment and prevention of risk factors for cardiovascular diseases
12/16/1997US5698536 Plasma-like substance
12/16/1997US5698524 Preparing water soluble reaction product polymer of lignin and lignoid that have each been extracted from wood or wood-like materials under acidic and/or alkaline conditions
12/16/1997US5698443 Tissue specific viral vectors
12/16/1997US5698436 Introduction and expression of foreign genetic material in epithelial cells
12/16/1997US5698228 Wound healing composition using squid chitin and fish skin collagen
12/16/1997US5698227 Compositions comprising lidocaine and emu oil and methods of use thereof
12/16/1997US5698194 Method for making a medicament for treating secondary immunodeficiency
12/16/1997US5697901 Gene delivery by microneedle injection
12/16/1997CA1339583C Monoclonal antibody nuh2 capable of inactivating motility of human sperm, antigen defined by said monoclonal antibody and methods of using said monoclonal antibody and antigen
12/11/1997WO1997046687A1 Vectors comprising sar elements
12/11/1997WO1997046683A2 Polynucleotides encoding secreted proteins
12/11/1997WO1997046682A2 Polynucleotides from human adult pbmc encoding secreted proteins
12/11/1997WO1997046672A2 Antisense nucleic acids and hammerhead ribozymes
12/11/1997WO1997046665A1 Method for making cartilage and implants
12/11/1997WO1997046262A2 Membrane incorporation of texaphyrins
12/11/1997WO1997046256A1 Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells
12/11/1997WO1997046245A1 Pharmaceutical composition which is stable during storage and contains a thymus extract
12/11/1997WO1997046224A1 Enteric coating, comprising alginic acid, for an oral preparation
12/11/1997WO1997046104A1 Treatment of diarrhea
12/11/1997WO1997046100A1 Serpin enzyme complex receptor-mediated gene transfer
12/11/1997WO1997039107A3 Methods for increasing the maturation of cells
12/11/1997DE19622422A1 Lagerungsstabile pharmazeutische Zusammensetzung mit immun - modulierenden und antiinflammatorischen Eigenschaften sowie ein Verfahren zu dessen Herstellung Storage stable pharmaceutical composition having immuno - modulatory and anti-inflammatory properties and a process for its preparation
12/11/1997DE19619505A1 Milk and bacterial lysate for use in cosmetics and drugs
12/11/1997CA2257225A1 Membrane incorporation of texaphyrins
12/11/1997CA2256558A1 Serpin enzyme complex receptor-mediated gene transfer
12/11/1997CA2256522A1 Polynucleotides encoding secreted proteins
12/11/1997CA2256484A1 Vectors comprising sar elements
12/10/1997EP0811412A1 Filter medium for leukocyte removal
12/10/1997EP0811078A1 Bcr-abl directed compositions and uses for inhibiting philadelphia chromosome stimulated cell growth
12/10/1997EP0811076A1 ISOLATED NUCLEIC ACID MOLECULE ENCODING PEPTIDES WHICH FORM COMPLEXES WITH MHC MOLECULE HLA-Cw*1601 AND USES THEREOF
12/10/1997EP0811075A1 A method for the isolation and purification of lipid cell-wall components
12/10/1997EP0811074A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
12/10/1997EP0811073A2 Methods and compositions for administering gene therapy vectors
12/10/1997EP0811069A1 Chimeric adenoviral fiber protein and methods of using same
12/10/1997EP0811062A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof
12/10/1997EP0811059A1 Human chemokine beta-11 and human chemokine alpha-1
12/10/1997EP0811057A1 Viral preparations, vectors, immunogens, and vaccines
12/10/1997EP0810881A1 Delivery of therapeutic agents by gene therapy
12/10/1997EP0810875A1 Multifunctional enzyme
12/10/1997EP0810874A1 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
12/10/1997EP0810870A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
12/10/1997EP0810867A1 Novel use of compositions containing mother-of-pearl
12/10/1997EP0810821A1 Method for diluting and preserving rabbit semen
12/10/1997EP0610246B1 Novel thrombin-inhibiting protein from ticks
12/10/1997CN1167146A Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
12/10/1997CN1167117A Method for extracting and preparing biological preparation using chitin as raw material and application thereof
12/10/1997CN1166985A Capsule for curing mammary gland hyperplasis
12/10/1997CN1166983A Nutritious oral liquid for improving quality and quantity of woman's milk and preparation method thereof
12/10/1997CN1166974A Muscular growth oil for treating injury
12/10/1997CN1166941A Healthc are food of black bone chicken
12/10/1997CN1166939A 蚂蚁酱油 Ant sauce
12/10/1997CN1166936A Ant jam
12/10/1997CN1166925A Bee-glue candy
12/09/1997US5696236 Method for the removal of viruses from protein solutions
12/09/1997US5695994 Isolated cytolytic T cells specific for complexes of MAGE related peptides and HLA molecules
12/09/1997US5695931 Nucleotide sequences coding for a protein with urease activity
12/09/1997US5695796 Fermented milk product
12/09/1997US5695785 Kidney extract for treatment of systematic lupus erythematosus
12/09/1997US5695759 An immunoadsorbent comprising a biocompatible solid support having atleast one identified carbohydrate xenoantigen to preformed antibodies attached thereto through biocompatible linker
12/09/1997US5695755 Peripheralization of hematopoietic stem cells
12/04/1997WO1997045550A2 Mini-adenoviral vector
12/04/1997WO1997045533A1 Engineering oral tissues
12/04/1997WO1997045531A1 Gonadotrophin releasor hormone-containing composition and method for treating infertility
12/04/1997WO1997045530A1 Use of streptococcus faecium strains and composition containing the same
12/04/1997WO1997045142A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
12/04/1997WO1997045128A1 Apoptosis associated protein bbk
12/04/1997WO1997045106A1 Identification of genes altered in multiple myeloma
12/04/1997WO1997045009A2 Long-term shelf preservation by vitrification
12/04/1997CA2257148A1 Mini-adenoviral vector
12/04/1997CA2256455A1 Identification of genes altered in multiple myeloma
12/04/1997CA2256372A1 Apoptosis associated protein bbk
12/04/1997CA2256333A1 Long-term shelf preservation by vitrification
12/04/1997CA2255941A1 Prevention of graft-versus-host disease with t-cells including polynucleotides encoding negative selective markers
12/03/1997EP0809704A1 Method for preparing a recombinant adenovirus genome
12/03/1997EP0809695A1 Transcription factor - e2f-5
12/03/1997EP0809692A1 Materials and methods relating to the regulation of polypeptide production in cells
12/03/1997EP0809517A1 Anti-transforming growth factor-beta gene therapy
12/03/1997EP0809516A1 Medicinal combination useful for in vivo exogenic transfection and expression
12/03/1997EP0809433A1 Systems and methods for removing free and entrained contaminants in plasma
12/03/1997EP0755516B1 A method for detecting and/or quantifying and/or separating apoptotic cells in or from a sample
12/03/1997EP0746343A4 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE -i(IN VIVO) OR -i(EX VIVO)
12/03/1997CN1166353A Oral medicine pill for curing myopia and amblyopia
12/03/1997CN1166348A Chinese medicine ointment for burn and its scar
12/03/1997CN1166346A Chinese medicine for curing thrombus, rheumatism and other diseases
12/03/1997CN1166341A Multiple-effect ointment for treating various surgical diseases
12/03/1997CN1166323A Health tonic made of bull penis and its preparation
12/03/1997CN1166322A Synergistic osteological traumatism medicine and its preparation method
12/03/1997CN1166321A Deer blood plasma and its application
12/03/1997CN1036592C Novel method for preparation and/or purification of clavulanic acid or pharmaceutical salt or ester of same
12/02/1997US5693775 Fibroblast growth factor homologous factor-1 (FHF-1) and methods of use
12/02/1997US5693762 Humanized immunoglobulins
12/02/1997US5693761 Genetic engineering; complementarity zones
12/02/1997US5693530 Recombinant vectors; vaccines
12/02/1997US5693514 Non-fibrogenic high mannuronate alginate coated transplants, processes for their manufacture, and methods for their use
12/02/1997US5693509 Adenovirus for delivering foreign DNA into higher eukaryotic cells
12/02/1997US5692302 Wound healing agent comprises pyruvic acid or salt, antioxidant, fatty acid mixture